Shinya Somiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shinya Somiya has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Hitoshi Yamada
Department of Urology Ijinkai Takeda General Hospital Kyoto Japan
3 shared publications- Toru Kanno
Department of Urology National Hospital Organization Kyoto Medical Center Kyoto Japan
3 shared publications Yoshihito Higashi
Department of Urology Ijinkai Takeda General Hospital Kyoto Japan
3 shared publications- Katsuhiro Ito
Department of Urology Kyoto University Graduate School of Medicine Kyoto Japan
2 shared publications Takao Haitani
Department of Urology Ijinkai Takeda General Hospital Kyoto Japan
2 shared publicationsTakashi Kobayashi
Kyoto University
2 shared publications
Latest Publications
- 6 June 2025
- Published by Springer Nature
- p. 115-125
Assessment of Force Thresholds Perceived as Safe by Expert Surgeons in Surgical Procedures
- 6 June 2025
- Published by Springer Nature
- p. 115-125
Assessment of Force Thresholds Perceived as Safe by Expert Surgeons in Surgical Procedures
- 14 February 2024
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 17 (2) , e13290
Minimally invasive total pelvic exenteration for symptomatic locally advanced prostate cancer with rectal invasion: Indications and technical considerations
In cases of rectal invasion by locally invasive prostate cancer (LAPC) leading to severe pain or bleeding, total pelvic exenteration (TPE) is necessary. Here, we present two cases of successful minimally invasive TPE: one performed laparoscopically for local recurrence with rectal bleeding after laparoscopic radical prostatectomy, and another done robotically for LAPC (clinical T4N1M0) accompanied by rectal bleeding. Medical treatments were ineffective in the latter case, and the tumor occupied a significant portion of the pelvis. We adopted a simultaneous transperineal approach and performed intracorporeal ileal conduit formation. Our cases highlight the challenging nature of minimally invasive TPE for symptomatic LAPC. Despite its complexity, these techniques prove viable and valuable in managing LAPC‐related symptoms, emphasizing their practical utility in clinical settings.
- 14 February 2024
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 17 (2) , e13290
Minimally invasive total pelvic exenteration for symptomatic locally advanced prostate cancer with rectal invasion: Indications and technical considerations
In cases of rectal invasion by locally invasive prostate cancer (LAPC) leading to severe pain or bleeding, total pelvic exenteration (TPE) is necessary. Here, we present two cases of successful minimally invasive TPE: one performed laparoscopically for local recurrence with rectal bleeding after laparoscopic radical prostatectomy, and another done robotically for LAPC (clinical T4N1M0) accompanied by rectal bleeding. Medical treatments were ineffective in the latter case, and the tumor occupied a significant portion of the pelvis. We adopted a simultaneous transperineal approach and performed intracorporeal ileal conduit formation. Our cases highlight the challenging nature of minimally invasive TPE for symptomatic LAPC. Despite its complexity, these techniques prove viable and valuable in managing LAPC‐related symptoms, emphasizing their practical utility in clinical settings.
- 6 June 2023
- Published by Wiley in International Journal of Urology
- Vol. 30 (10) , 853-858
Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi‐institutional cohort
Introduction: This study aimed to identify preoperative risk factors and create a risk classification for intravesical recurrence of upper urinary tract urothelial carcinoma only after laparoscopic radical nephroureterectomy in a multi‐institutional cohort.Methods: We retrospectively analyzed 283 patients who had undergone laparoscopic radical nephroureterectomy for nonmetastatic upper tract urothelial cancer between March 2002 and March 2020. The cumulative incidence of intravesical recurrence for 224 patients without previous or concomitant bladder cancer was examined using multivariate Fine‐Gray competing risks proportional hazards models. A risk stratification model was created to predict subsequent patient outcomes based on the results.Results: The median follow‐up duration was 33.3 months, and 71 (31.7%) patients experienced intravesical recurrence. The estimated cumulative incidence of intravesical recurrence at one and 5 years was 23.5% and 36.4%, respectively. In multivariate analysis, the presence of ureter tumors and multiple tumors were shown to be independently significant predictive factors for intravesical recurrence. Based on the results, we classified patients into three risk groups. The cumulative incidence rates of intravesical recurrence within 5 years after surgery were 24.4%, 42.5%, and 66.7% in the low‐, intermediate‐, and high‐risk groups, respectively.Conclusions: We identified risk factors and created a risk classification model for intravesical recurrence of upper urinary tract urothelial carcinoma only after laparoscopic radical nephroureterectomy. Based on this model, an individualized surveillance protocol or adjuvant therapy could be provided.
- 6 June 2023
- Published by Wiley in International Journal of Urology
- Vol. 30 (10) , 853-858
Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi‐institutional cohort
Introduction: This study aimed to identify preoperative risk factors and create a risk classification for intravesical recurrence of upper urinary tract urothelial carcinoma only after laparoscopic radical nephroureterectomy in a multi‐institutional cohort.Methods: We retrospectively analyzed 283 patients who had undergone laparoscopic radical nephroureterectomy for nonmetastatic upper tract urothelial cancer between March 2002 and March 2020. The cumulative incidence of intravesical recurrence for 224 patients without previous or concomitant bladder cancer was examined using multivariate Fine‐Gray competing risks proportional hazards models. A risk stratification model was created to predict subsequent patient outcomes based on the results.Results: The median follow‐up duration was 33.3 months, and 71 (31.7%) patients experienced intravesical recurrence. The estimated cumulative incidence of intravesical recurrence at one and 5 years was 23.5% and 36.4%, respectively. In multivariate analysis, the presence of ureter tumors and multiple tumors were shown to be independently significant predictive factors for intravesical recurrence. Based on the results, we classified patients into three risk groups. The cumulative incidence rates of intravesical recurrence within 5 years after surgery were 24.4%, 42.5%, and 66.7% in the low‐, intermediate‐, and high‐risk groups, respectively.Conclusions: We identified risk factors and created a risk classification model for intravesical recurrence of upper urinary tract urothelial carcinoma only after laparoscopic radical nephroureterectomy. Based on this model, an individualized surveillance protocol or adjuvant therapy could be provided.
- Open Access
- 3 May 2021
- Published by Wiley in IJU Case Reports
- Vol. 4 (4) , 232-234
Retrograde ureteroscopic lithotripsy in cross‐fused renal ectopia
- 3 May 2021
- Published by Wiley in IJU Case Reports
- Vol. 4 (4) , 232-234
Open AccessRetrograde ureteroscopic lithotripsy in cross‐fused renal ectopia
- Open Access
- 1 September 2020
- Published by Elsevier in Urology Case Reports
- Vol. 32, 101196
Successful surgical management of recurrent urachal adenocarcinoma: A case report
- 1 September 2020
- Published by Elsevier in Urology Case Reports
- Vol. 32, 101196
Open AccessSuccessful surgical management of recurrent urachal adenocarcinoma: A case report